Announcements Trials
Browse Landscape

Phase

Phase NA 228Phase 2 10Phase 3 9Phase 2/3 3Phase 1 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Thoracic 1Sarcoma 1Other 1Head & Neck 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 117Triple Negative Breast Neoplasms 9Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4HER2-positive Breast Cancer 4Prostatic Neoplasms 3Motor Activity 3Melanoma 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Depression 3Colorectal Neoplasms 3Sarcoma 2Peripheral Nervous System Diseases 2Ovarian Neoplasms 2Fatigue 2Carcinoma, Ductal, Breast 2Breast Diseases 2Breast Carcinoma In Situ 2Anxiety Disorders 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urinary Incontinence 1To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients 1Smoking 1Sleepiness 1Seroma 1Recurrence 1Radiodermatitis 1

Interventions

Mindfulness-Based Stress Reduction 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Motor Activity × Breast × Clear all
NCT00221221 2024-11-05

Physical Activity Promotion in Breast Cancer Survivors

University of Alberta

Phase 2/3 Completed
300 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT00393172 2019-11-01

WISER

University of Minnesota

Phase 2/3 Completed
400 enrolled
BreastOther

Breast Neoplasms, Motor Activity, Obesity

NCT00990977 2015-06-30

MICA

Danish Cancer Society

Phase 2/3 Completed
336 enrolled
Breast

Alcohol Drinking, Anxiety Disorders, Breast Neoplasms, Depression, Motor Activity, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡